It is suggested that, in SAS patients, the upregulation of REG IV and HGF may function against the apoptosis of cardiomyocytes, leading to the maintenance of cardiac functions, and that miR-499 could play a crucial role in the regulation of these gene expressions. The gene discussed is HGF; the disease is SATB2 associated disorder.